ATE309355T1 - Gas1-polypeptide - Google Patents
Gas1-polypeptideInfo
- Publication number
- ATE309355T1 ATE309355T1 AT00962353T AT00962353T ATE309355T1 AT E309355 T1 ATE309355 T1 AT E309355T1 AT 00962353 T AT00962353 T AT 00962353T AT 00962353 T AT00962353 T AT 00962353T AT E309355 T1 ATE309355 T1 AT E309355T1
- Authority
- AT
- Austria
- Prior art keywords
- protein
- gas1
- lethal
- cell
- sequence encoding
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4702—Regulators; Modulating activity
- C07K14/4703—Inhibitors; Suppressors
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Genetics & Genomics (AREA)
- Neurology (AREA)
- Zoology (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Diabetes (AREA)
- Psychology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biotechnology (AREA)
- Toxicology (AREA)
- General Engineering & Computer Science (AREA)
- Gastroenterology & Hepatology (AREA)
- Wood Science & Technology (AREA)
- Immunology (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Hematology (AREA)
- Dermatology (AREA)
- Physics & Mathematics (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Plant Pathology (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP99306702 | 1999-08-24 | ||
PCT/EP2000/008182 WO2001014549A1 (en) | 1999-08-24 | 2000-08-21 | Gas1 polypeptides |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE309355T1 true ATE309355T1 (de) | 2005-11-15 |
Family
ID=8241594
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT00962353T ATE309355T1 (de) | 1999-08-24 | 2000-08-21 | Gas1-polypeptide |
Country Status (14)
Country | Link |
---|---|
US (1) | US20080085861A1 (de) |
EP (1) | EP1212421B1 (de) |
JP (1) | JP2003507067A (de) |
KR (1) | KR20020019572A (de) |
AT (1) | ATE309355T1 (de) |
AU (1) | AU783872B2 (de) |
CA (1) | CA2382674A1 (de) |
DE (1) | DE60023921T2 (de) |
ES (1) | ES2253251T3 (de) |
IL (1) | IL148311A0 (de) |
NO (1) | NO20020916L (de) |
NZ (1) | NZ516870A (de) |
WO (1) | WO2001014549A1 (de) |
ZA (1) | ZA200201478B (de) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
MX361195B (es) * | 2014-05-23 | 2018-11-13 | Centro De Investig Y De Estudios Avanzados Del I P N | Sistema de nanoparticulas genicas con efecto apoptotico y especificidad tumoral para el tratamiento de cancer. |
-
2000
- 2000-08-21 DE DE60023921T patent/DE60023921T2/de not_active Expired - Fee Related
- 2000-08-21 WO PCT/EP2000/008182 patent/WO2001014549A1/en active IP Right Grant
- 2000-08-21 EP EP00962353A patent/EP1212421B1/de not_active Expired - Lifetime
- 2000-08-21 AT AT00962353T patent/ATE309355T1/de not_active IP Right Cessation
- 2000-08-21 NZ NZ516870A patent/NZ516870A/en unknown
- 2000-08-21 JP JP2001518862A patent/JP2003507067A/ja not_active Withdrawn
- 2000-08-21 AU AU74117/00A patent/AU783872B2/en not_active Ceased
- 2000-08-21 IL IL14831100A patent/IL148311A0/xx unknown
- 2000-08-21 CA CA002382674A patent/CA2382674A1/en not_active Abandoned
- 2000-08-21 KR KR1020027001048A patent/KR20020019572A/ko active IP Right Grant
- 2000-08-21 ES ES00962353T patent/ES2253251T3/es not_active Expired - Lifetime
-
2002
- 2002-02-21 ZA ZA200201478A patent/ZA200201478B/en unknown
- 2002-02-25 NO NO20020916A patent/NO20020916L/no not_active Application Discontinuation
-
2007
- 2007-03-27 US US11/691,714 patent/US20080085861A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
CA2382674A1 (en) | 2001-03-01 |
AU783872B2 (en) | 2005-12-15 |
US20080085861A1 (en) | 2008-04-10 |
JP2003507067A (ja) | 2003-02-25 |
AU7411700A (en) | 2001-03-19 |
KR20020019572A (ko) | 2002-03-12 |
ES2253251T3 (es) | 2006-06-01 |
DE60023921T2 (de) | 2006-08-10 |
NO20020916D0 (no) | 2002-02-25 |
DE60023921D1 (en) | 2005-12-15 |
ZA200201478B (en) | 2004-04-28 |
NO20020916L (no) | 2002-04-24 |
EP1212421A1 (de) | 2002-06-12 |
EP1212421B1 (de) | 2005-11-09 |
WO2001014549A1 (en) | 2001-03-01 |
IL148311A0 (en) | 2002-09-12 |
NZ516870A (en) | 2003-10-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE485371T1 (de) | Varianten des menschlichen koagulationsfaktors vii | |
BRPI0412401A (pt) | polipeptìdeos da amilase exoespecìficos, ácidos nucléicos que codificam tais polipeptìdeos e usos dos mesmos | |
NO20031129D0 (no) | Varianter av human koagulasjonsfaktor VII | |
WO2003104270A3 (en) | GENES OF DUDULINE 2, EXPRESSION PRODUCTS, NON-HUMAN ANIMAL MODEL: USES IN HUMAN HEMATOLOGICAL DISEASES | |
MXPA02005337A (es) | Control biologico por sistema generico letal, dominante, condicional. | |
DE60330923D1 (de) | Menschliche Koagulationsfaktor VII Polypeptide | |
EA200600868A1 (ru) | Гидрогенолиз сахарного сырья | |
EE04685B1 (et) | Ravimi lbimiskiirust kontrolliv membraan v?i maatriks | |
BR0009170A (pt) | ácidos nucléicos akt, polipeptìdeos e uso dos mesmos | |
DK1290160T3 (da) | Humane Pellino-polypeptider | |
ATE309355T1 (de) | Gas1-polypeptide | |
ATE327253T1 (de) | Proteine und nukleinsäuremoleküle des kopfes, des nervenkords, der tieferen darmabschnitte und des malpighi-gefässes des flohs und ihre verwendungen | |
PT928197E (pt) | Utilizacao de proteinas como agentes contra doencas de natureza autoimunitaria | |
DK1075523T3 (da) | Strukturelle proteiner hos fiskepankreassygdomsvirus og anvendelser deraf | |
WO2001045738A3 (en) | Use of heat shock proteins to enhance production of chemokines by a cell | |
ATE322906T1 (de) | Verwendung von langem pentraxin ptx3 zur behanlung von durch geänderte aktivität des fgf-2 wachstumsfaktors hervorgerufene krankheiten | |
DK1339853T3 (da) | Isolerede luciferaser og deres anvendelse | |
DE69732246D1 (de) | Gewebespezifische expression des retinoblastoma-proteins | |
NO995692D0 (no) | Nye BPC-peptidsalter med organbeskyttende aktivitet, metoden for deres fremstilling og deres anvendelse | |
DK0774004T3 (da) | DNA-sekvens, som koder for de humane proteiner Tx og Ty, der er beslægtede med Interleukin-1betakonverterende enzym | |
NO952601L (no) | Oligonukleotider for inhibering av ekspresjon av isoprenylprotein-transferaser | |
NO20016089D0 (no) | Nuklein- og proteinsyrer som svarer til det humane gen ABC1 | |
FI20000182A0 (fi) | Nukleotidisekvenssien käyttö proteiinisynteesin ja proteiinien ilmentämisen lisäämiseksi | |
IT1316921B1 (it) | Organo bioartificiale per ospitare cellule animali e/o umane. | |
DE60129228D1 (de) | Humane 7-transmembranproteine und dafür codierende polynukleotide |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |